IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens Following Neoadjuvant Therapies

Small Steps Forward in SCLC: Is a Giant Leap on the Horizon?

Liquid biopsy for early lung cancer detection and cancer interception

Telehealth: Bridging the Digital Divide Is Still a Work In Progress

Timing of Immune Checkpoint Inhibitors With Respect to Molecular Testing in NSCLC

Bringing Telehealth to the Front Lines of Lung Cancer Care in the COVID-19 Pandemic

Conducting a Lung Multidisciplinary Tumor Board at the National University Cancer Institute, Singapore

Patient Perspectives on Telehealth During COVID-19: Balancing Fear, Self-Advocacy

Expanding Efforts Help Address Disparities in Lung Cancer Care

An Early Look at Adjuvant Osimertinib Shows a Dramatic Improvement in Disease-Free Survival

Expanding Efforts Help Address Disparities in Lung Cancer Care

Dr. Harpreet Singh Discusses the Conduct of FDA Clinical Trials During the COVID-19 Pandemic